statements

Biogen Pharmachem Industries Ltd.

BSE: 531752

Sector: Financial Services

Industry Group: Finance

Industry: Other Financial Services

0.28+0.0 (+3.70%)

25 Aug, 12:00 AM

Overview Analysis Statements

Technicals Forecast Peers Resources News

Income Statement

Abridged

Understanding Income Statement

Biogen Pharmachem Industries Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	C 2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
	2012 Mar 31	C 2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS	12M IR
Total Revenue	0.04	-	-	-	-	-	-	0.95	-	1.62	2.47	0.66	1.59	-	-	-
Cost of Operating Revenue	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.91	-	1.48	2.02	-	-	-	-	-
Total Operating Expenses	0.14	0.13	0.13	0.14	0.03	0.12	6.72	0.95	0.12	3.23	2.49	0.46	0.45	1.49	1.60	1.63
Operating Profit	-0.10	-0.13	-0.13	-0.14	-0.03	-0.12	-6.72	0.00	-0.12	-1.60	-0.02	0.21	1.14	-1.49	-1.60	-1.63
Operating Margin	-215.3	-	-	-	-	-	-	-0.4	-	-98.8	-0.6	31.0	71.7	-	-	-
Profit before Taxes	-0.10	-0.13	-0.13	-0.13	-0.03	-0.12	-6.56	0.00	-0.12	-1.60	-0.01	0.46	1.93	-0.29	0.96	-0.17
Income Taxes	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.10	-
Profit after Tax	-0.10	-0.13	-0.13	-0.13	-0.03	-0.12	-6.56	0.00	-0.12	-1.60	-0.01	0.46	1.93	-0.29	0.86	-0.17
PAT Margin	-215.3	-	-	-	-	-	-	-0.4	-	-98.8	-0.3	68.8	121.2	-	-	-
EPS - Basic - ex Extraordinary Items	0.00	0.00	0.00	0.00	0.00	0.00	-0.09	-	0.00	-0.02	0.00	0.01	0.03	0.00	0.01	0.00
EPS - Diluted - ex Extraordinary Items	0.00	0.00	0.00	0.00	0.00	0.00	-0.09	-	0.00	-0.02	0.00	0.01	0.03	0.00	0.01	0.00
EBIT	-0.10	-0.13	-0.13	-0.14	-0.03	-0.12	-6.72	0.00	-0.12	-1.60	-0.02	0.21	1.14	-1.49	-1.60	-1.63
EBITDA	0.00	-0.04	-0.03	-0.04	-0.03	-0.12	-6.72	0.00	-0.12	-1.60	-0.02	0.21	1.14	-1.49	-1.60	-1.63
EBITDA Margin	5.6	-	-	-	-	-	-	-0.4	-	-98.8	-0.6	31.0	71.7	-	-	-

Balance Sheet

Abridged

Understanding Balance Sheet

Biogen Pharmachem Industries Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	C 2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	C 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2012 Mar 31	C 2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	C 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Source:	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	PRESS
Property Plant & Equipment - Net	0.00	0.00	0.00	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	67.18	65.14	123.26	73.49	68.81	63.25	55.93	57.63	56.09	54.25	54.95	54.83	56.82	92.02	99.40
Long Term Debt	-	-	-	6.94	6.21	0.72	0.01	0.63	0.31	-	-	-	-	-	-
Total Liabilities	5.79	3.89	62.14	12.50	7.85	2.41	1.65	3.36	0.35	0.11	0.82	0.24	0.30	0.09	0.31
Total Shareholders' Equity	61.39	61.25	61.12	60.99	60.96	60.84	54.28	54.27	55.75	54.14	54.13	54.59	56.52	91.93	99.09
Total Equity	61.39	61.25	61.12	60.99	60.96	60.84	54.28	54.27	55.75	54.14	54.13	54.59	56.52	91.93	99.09
Total Liabilities & Equity	67.18	65.14	123.26	73.49	68.81	63.25	55.93	57.63	56.09	54.25	54.95	54.83	56.82	92.02	99.40
Total Current Assets	25.11	46.27	47.53	30.26	14.21	0.06	7.06	8.04	8.04	2.56	1.93	0.15	0.09	2.67	0.49
Total Current Liabilities	4.20	2.30	60.55	3.97	0.05	0.10	0.05	1.14	0.04	0.11	0.82	0.24	0.30	0.09	0.21

Cash Flow

Abridged

Understanding Cash Flow Statement

Biogen Pharmachem Industries Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Operating CF bef Changes in Working Cap	-0.09	-0.13	-0.13	-0.13	-0.03	-0.12	-6.56	0.00	-0.12	-1.60	-0.01	0.46	1.93	-0.29	0.96
Working Capital - Increase/(Decrease)	-9.47	22.33	0.19	-7.14	4.71	0.05	-7.08	0.09	-1.10	5.55	1.41	1.25	0.01	-0.79	0.61
Net CF from Operating Activities	-9.56	22.19	0.06	-7.28	4.68	-0.07	-13.65	0.09	-1.21	3.95	1.40	1.70	1.94	-1.08	1.57
Capital Expenditures - Net	-	-	-	0.00	-	-	-	-	-	-	-	-	-	-	-
Net CF from Investing Activities	13.77	-46.12	-8.99	17.08	17.08	4.30	14.32	-0.72	1.54	-3.64	-1.32	-1.66	-2.06	-32.62	-9.56
Stock - Issuance/(Retirement) - Net	-	-	-	-	-	-	-	-	-	-	-	-	-	35.70	6.30
Debt - LT & ST - Issuance/(Retirement) - Total	4.00	-4.00	57.21	-47.21	-3.79	-4.31	-0.71	0.62	-0.32	-0.31	-	-	-	-	-
Net Cash Flow from Financing Activities	-4.15	23.89	10.33	-11.19	-21.74	-4.31	-0.71	0.62	-0.32	-0.31	-	-	-	35.70	6.30
Free Cash Flow to Equity	-5.56	18.19	57.26	-54.48	0.89	-4.37	-14.36	0.71	-1.54	3.64	1.40	1.70	1.94	-1.08	-
Free Operating CF net dividend	-9.56	22.19	0.06	-	4.68	-0.07	-13.65	0.09	-1.21	3.95	1.40	1.70	1.94	-1.08	1.57
Free Operating CF	-9.56	22.19	0.06	-	4.68	-0.07	-13.65	0.09	-1.21	3.95	1.40	1.70	1.94	-1.08	1.57

Business Segment Analysis

Biogen Pharmachem Industries Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

We don't have enough data to show business segment analysis for Biogen Pharmachem Industries Ltd.

Regional Segment Analysis

Biogen Pharmachem Industries Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Biogen Pharmachem Industries Ltd.

Historical Segment Analysis

Track how Biogen Pharmachem Industries Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

We don't have enough data to show segments for Biogen Pharmachem Industries Ltd.

Frequently Asked Questions

What is the revenue of Biogen Pharmachem Industries Ltd.?

The latest trailing twelve month revenue of Biogen Pharmachem Industries Ltd. is ₹ 0.00 Cr. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Biogen Pharmachem Industries Ltd.?

The latest trailing twelve month net profit (PAT) of Biogen Pharmachem Industries Ltd. is ₹ -0.17 Cr, with a 3-year earnings CAGR of -27.02%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Biogen Pharmachem Industries Ltd.?

The operating margin of Biogen Pharmachem Industries Ltd. is -. Detailed EBITDA history is available in the Income Statement section of the Statements tab.

What is the EPS of Biogen Pharmachem Industries Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Biogen Pharmachem Industries Ltd. is 0.00. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Biogen Pharmachem Industries Ltd.?

The debt-to-equity ratio of Biogen Pharmachem Industries Ltd. stands at 0.00. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Biogen Pharmachem Industries Ltd.?

The estimated book value per share of Biogen Pharmachem Industries Ltd. is 0.94 (derived from a P/B ratio of 0.30 and market price of ₹ 0.28), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Biogen Pharmachem Industries Ltd.?

The trailing twelve month operating cash flow of Biogen Pharmachem Industries Ltd. is ₹ 1.57 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Biogen Pharmachem Industries Ltd. report consolidated or standalone financials?

Biogen Pharmachem Industries Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.